Showing 1 - 10 of 102,827
then use the data to consider some key issues in dynamic competition and innovation. We look at the incidence and … distribution of patent races by technology, evidence for strategic delay of innovation by incumbent firms, and evidence that patent …
Persistent link: https://www.econbiz.de/10014061822
innovation. The dataset is complemented with indicators of patent quality (patent renewal, forward citations, and patent family …
Persistent link: https://www.econbiz.de/10012615417
This paper examines the intertemporal returns of patented inventions using estimates of patent value obtained from German employee inventors’ compensation records. The paper finds heterogeneity in the mean age and dispersion of the annual returns by technology and cumulative patent value....
Persistent link: https://www.econbiz.de/10010906511
innovation. The dataset is complemented with indicators of patent quality (patent renewal, forward citations, and patent family …
Persistent link: https://www.econbiz.de/10012259861
Critics claim that patent screening is ineffective, granting low-quality patents that impose unnecessary social costs. We develop an integrated framework, involving patent office examination, fees, and endogenous validity challenges in the courts, to study patent screening both theoretically and...
Persistent link: https://www.econbiz.de/10013226280
This paper provides causal evidence of local innovation spillovers, i.e. innovation by one firm fostering innovation by … neighboring firms. First, I document that exogenous shocks to innovation by listed firms affect innovation by private firms in the … same geographical area. I also find that such local innovation spillovers decline rapidly with distance. Second, I find …
Persistent link: https://www.econbiz.de/10013235778
We study how fragmentation of patent rights ('patent thickets') and the formation of the Court of Appeal for the Federal Circuit (CAFC) affected the duration of patent disputes, and thus the speed of technology diffusion through licensing. We develop a model of patent litigation which predicts...
Persistent link: https://www.econbiz.de/10013117066
Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of the underlying invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent invalidation during drug development renders data...
Persistent link: https://www.econbiz.de/10012064786
We investigate the causal effect of patent rights on cumulative innovation, using large-scale data that approximate the …
Persistent link: https://www.econbiz.de/10012863982
We show that examiner-driven variation in patent rights leads to quantitatively large impacts on several patent outcomes, including patent value, citations, and litigation. Notably, Patent Assertion Entities (PAEs) overwhelmingly purchase patents granted by "lenient" examiners. These examiners...
Persistent link: https://www.econbiz.de/10012855159